Meeting Regulatory Approval and Improving Distribution Operations across the Middle East
Add bookmark
Meeting Regulatory Approval and Improving Distribution Operations across the Middle East
Add bookmark
In this interview Hassan Bibi, Regional Regulatory Affairs Director NEWAAT - Janssen Pharmaceutical companies of Johnson and Johnson, speaks to Andrea Charles from Pharma IQ, about overcoming the 3 main challenges with regards to meeting regulatory approval and improving distribution operations across the Middle East. Bibi also shares his thoughts on the measures being taken to reduce counterfeiting in the pharmaceutical supply chain and how regulatory authorities and the pharmaceutical industry are working closer together in the Middle East to develop legislation and regulatory practices that enable patients to have access to good quality medicines.
[inlinead]
|
|
Have Your Say Rate this feature and give us your feedback in the comments section below |
Tags:
Hassan Bibi
Janssen
regulatory affairs
Middle East
logistics Middle East
pharma logistics
pharmaceutical distribution
regulatory approval
